Holds and Ohhhh Booooyyyy The $NBI is in for a 200 pt run
SOOOooo Issac - YOU too are down to "Ohhhh We're going to have Buy Out". I didn't think that you'd stoop that low too Issc
Continued with a few skipped paragraphs:
"In recent months, Germany's Merck and Co. gained accelerated FDA approval for its immunotherapy treatment for lung cancer, Keyruda. Embattled Canadian pharmaceutical giant Valeant also owns the rights to a metastatic prostate cancer immunotherapy known as Provenge."
COULD ASH spark more ETF interest??????
"In this image, tiny beads (yellow) are used to force T-cells to divide before they are given to leukemia patients.
One of the most promising long-term investment opportunities could be a cancer treatment known as immunotherapy, according to UBS's global chief investment officer.
"This emerging science offers the potential for attractive returns," said Mark Haefele, who oversees the investment policy and strategy for $2 trillion.
Immunotherapy is an increasingly popular cancer treatment that, roughly put, trains the body's immune system to aggressively attack cancerous cells that wouldn't ordinarily be recognized as threatening.
The immune system often overlooks cancer cells, but multiple types of immunotherapy have been developed in the past decade to address that.
Some treatments create proteins that bind to cancerous cells, marking them for the immune system. Another treatment involves extracting the white blood cells most active against tumors in the patient's body, and genetically modifying the cells to specifically attack cancerous ones."
'A hope they couldn't have fathomed'
"The treatment came into focus just a few years ago, when clinical trials started showing promising results. In a 2013 test by Bristol-Myers Squibb, 22% of the 1,800 advanced melanoma patients treated with immunotherapy Yervoy were alive three years later.
"For physicians accustomed to losing every patient with advanced disease, the numbers bring a hope they couldn't have fathomed a few years ago," wrote Jennifer Couzin-Frankel for Science Magazine, after naming cancer immunotherapy as the breakthrough of 2013."
-- CONTINUED (well... Hopefully...if Yayhoo let's it post)
CTIC... Just an FYI re: The $90MM ATM --- It is NOT effective as of 11/25/2015. Until it is made EFFECTIVE they can not be sold (at least that's my understanding - anyone correct me if they can point to SEC Regulatory info that contradicts this please)
SUNE now effectively bouncing the $3.49 and volume intraday drastically decreasing per tick on the 15 mins. (traders leave for holiday already???) ANY WAY... Those were the Levels....
YEP... $26.91 is a Level that had to watch for a Temp pull back... Intraday S1 $26.22; S2 $25.69...
After the pull back the next level up goes to $28.02
You need to Watch, Levels......
Pull Backs aren't always a "Bad" thing... IN FACT I firmly believe they are a Good thing and get rid of the weak kneed holders that then usually just go away......
When SUNE re-Breaks $3.91.......... Better load the boat... She's going to $5.02 and THEN after most likely a pull back (though if they do what they did yesterday all you'll see is a pause sideways.... THEN it goes to $7.00
MY SUNE Mid Term call is $7.00
So now you'll see the Run to $28.59 - $29.04........ WARNED
I kept telling everyone "Boobster" and "Vette" lived in a Pakistani hut. THEY'RE BUSTED!